{"organizations": [], "uuid": "75faceca17cbc9adcaff25546629fffab55f2c17", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/02/22/the-associated-press-nevro-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Nevro reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T00:07:00.000+02:00", "replies_count": 0, "uuid": "75faceca17cbc9adcaff25546629fffab55f2c17"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/02/22/the-associated-press-nevro-reports-4q-loss.html", "ord_in_thread": 0, "title": "Nevro reports 4Q loss", "locations": [], "entities": {"persons": [{"name": "nevro", "sentiment": "negative"}], "locations": [{"name": "redwood city", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "redwood city", "sentiment": "none"}], "organizations": [{"name": "nevro corp.", "sentiment": "negative"}, {"name": "nvro", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "REDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Thursday reported a loss of $4.3 million in its fourth quarter.\nThe Redwood City, California-based company said it had a loss of 15 cents per share.\nThe results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.\nThe maker of an electrical implant that treats leg and back pain posted revenue of $98 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $97.6 million.\nFor the year, the company reported that its loss widened to $36.7 million, or $1.25 per share. Revenue was reported as $326.7 million.\nNevro expects full-year revenue in the range of $400 million to $410 million.\nNevro shares have risen 15 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $79.41, a drop of 18 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on NVRO at https://www.zacks.com/ap/NVRO", "external_links": [], "published": "2018-02-23T00:07:00.000+02:00", "crawled": "2018-02-23T01:05:04.000+02:00", "highlightTitle": ""}